BLVRB Antikörper (Middle Region)
-
- Target Alle BLVRB Antikörper anzeigen
- BLVRB (Flavin Reductase (BLVRB))
-
Bindungsspezifität
- Middle Region
- Reaktivität
- Human, Maus, Ratte, Pferd, Hund, Meerschweinchen, Kaninchen, Rind (Kuh)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BLVRB Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- GLKYVAVMPP HIGDQPLTGA YTVTLDGRGP SRVISKHDLG HFMLRCLTTD
- Homologie
- Cow: 93%, Dog: 100%, Guinea Pig: 100%, Horse: 86%, Human: 100%, Mouse: 100%, Rabbit: 92%, Rat: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against BLVRB. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human BLVRB
- Top Product
- Discover our top product BLVRB Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 206 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors." in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 35, Issue 5, pp. 475-80, (2009) (PubMed).
: "
-
Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors." in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 35, Issue 5, pp. 475-80, (2009) (PubMed).
-
- Target
- BLVRB (Flavin Reductase (BLVRB))
- Andere Bezeichnung
- BLVRB (BLVRB Produkte)
- Synonyme
- BVRB antikoerper, FLR antikoerper, SDR43U1 antikoerper, biliverdin reductase B (flavin reductase (NADPH)) antikoerper, biliverdin reductase B antikoerper, Blvrb antikoerper, BLVRB antikoerper
- Hintergrund
-
BLVRB catalyzes electron transfer from reduced pyridine nucleotides to flavins as well as methylene blue, pyrroloquinoline quinone, riboflavin, or methemoglobin. BLVRB has possible role in protecting cells from oxidative damage or in regulating iron metabolism. In the liver, BLVRB converts biliverdin to bilirubin.
Alias Symbols: BVRB, FLR, MGC117413, SDR43U1
Protein Interaction Partner: SUMO1, NEDD8, UBC, RPL31, ORM1, GMDS, HMOX1,
Protein Size: 206 - Molekulargewicht
- 22 kDa
- Gen-ID
- 645
- NCBI Accession
- NM_000713, NP_000704
- UniProt
- P30043
-